- Christophe Richez,
- Marie-Elise Truchetet,
- Marie Kostine,
- Thierry Schaeverbeke,
- Bernard Bannwarth
Expert Opin Pharmacother 2017 Jul 24. Epub 2017 Jul 24.
a Département de Rhumatologie , FHU ACRONIM CHU Bordeaux , Hôpital Pellegrin, 33076 Bordeaux , France.
Introduction Although the outcome for patients with rheumatoid arthritis (RA) has improved in the past decades, adequate disease control cannot be achieved in a substantial proportion of patients. New drugs with a novel mechanism of action, may represent a valuable addition to the current armamentarium. Areas covered This review focuses on the pharmacodynamics and pharmacokinetics of baricitinib. Read More